Haloperidol Syringe Driver — SCE Medical Oncology MCQ

Instant feedback + full explanation. One question, done properly.

ModerateSupportive & Palliative OncologyHaloperidol Syringe DriverSCE Medical Oncology

A 65-year-old man with cancer on opioids needs an anti-emetic in the syringe driver. What is first-line?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: C — Haloperidol 1.5-5 mg/24h SC — D2 antagonist at CTZ; compatible with most syringe driver combinations (morphine, midazolam, hyoscine butylbromide)

Haloperidol: first-line syringe driver anti-emetic for opioid/metabolic nausea. D2 antagonism at CTZ. Typical dose 0.5-1.5mg/24h. Levomepromazine is rescue for refractory nausea.

Reference: Palliative Care Formulary; NICE NG31